Trevi Therapeutics
Developing oral nalbuphine ER across three chronic-cough indications.
$16.72
After-hours close−0.06 (−0.34%)
At close$16.78(−6.57%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 107.00%Insiders 0.37%
A 13F quarter can total more than the shares outstanding — sub-advisers file the same block twice, and a filer's own share count can be a quarter stale. No split is drawn from it.
Shares outstanding 141.98M · Float 118.77M · 83.7% free float
Institutions13F, as of Jun 30, 2026
225 holders · 151.92M shares · 45 new positions · 135 increased · 60 reduced · 22 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Nea Management Company, LLC | 13.22M | 9.31% | 0 | Aug 14, 2026 |
| FMR LLC | 12.56M | 8.85% | +4.52M | Aug 13, 2026 |
| BlackRock, Inc. | 11.16M | 7.86% | +914.8K | Aug 7, 2026 |
| Frazier Life Sciences Management, L.P. | 9.94M | 7.00% | −100 | Aug 14, 2026 |
| Wellington Management Group LLP | 5.68M | 4.00% | +495.5K | Aug 14, 2026 |
| Vanguard Capital Management LLC | 5.53M | 3.90% | +552.1K | Aug 13, 2026 |
| Vivo Capital, LLC | 5.09M | 3.59% | 0 | Aug 14, 2026 |
| Woodline Partners LP | 4.08M | 2.87% | +3.08M | Aug 14, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Nea 18 Vge GP, LLCincl. Ali Behbahani, Carmen Chang +10 more | 10.50% | 15.07M | 13D | May 7, 2026 ↗ |
| Frazier Life Sciences Public Fund, L.P. | 7.00% | 8.51M | 13G | Nov 14, 2025 ↗ |
| FMR LLC | 6.30% | 8.04M | 13G | May 6, 2026 ↗ |
| BlackRock, Inc. | 5.60% | 6.80M | 13G | Oct 17, 2025 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| Behbahani Ali | 10 percent owner | 948.9K | 0.67% | Feb 13, 2026 |
| Chang Carmen | 10 percent owner | 948.9K | 0.67% | Feb 13, 2026 |
| Florence Anthony A. Jr. | 10 percent owner | 948.9K | 0.67% | Feb 13, 2026 |
| Makhzoumi Mohamad | 10 percent owner | 948.9K | 0.67% | Feb 13, 2026 |
| Sandell Scott D | 10 percent owner | 948.9K | 0.67% | Feb 13, 2026 |
| Walker Paul Edward | 10 percent owner | 948.9K | 0.67% | Feb 13, 2026 |
| Thomas Sciascia | officer: Chief Scientific Officer | 221.4K | 0.16% | Mar 26, 2025 |
| Jennifer L. Good | director, officer: President & CEO | 213.3K | 0.15% | Mar 25, 2025 |
| Farrell Simon | officer: Chief Commercial Officer | 63.2K | 0.04% | Mar 12, 2025 |
| Christopher Galletta | officer: See Remarks | 26.1K | 0.02% | Dec 3, 2025 |
21 ten-percent owners hold 36.82M shares by Form 4, outside the officers-and-directors figure above · 10 people have not refiled in the last 18 months (27.78M shares), so they are not in the figure above
Latest trades
No open-market trades in the last 12 months.
CongressHouse and Senate disclosures
Not reported.